Long-term follow-up of a child with Rabson—Mendenhall syndrome

A case of Rabson—Mendenhall syndrome in a boy is described. Rabson—Mendenhall syndrome is an extremely rare form of insulin resistance and is characterized by a severe course. To date, less than 50 cases of the syndrome have been reported around the world. Its prevalence is unknown because cases ending in death at early age often remain undiagnosed. The most pathognomonic features include acanthosis nigricans and hyperkeratosis of the skin in the area of natural folds, which reflect insulin resistance. Diabetes mellitus in children with Rabson—Mendenhall syndrome develops in childhood and has a labile course, which is manifested by frequent ketoacidosis episodes. Severe insulin resistance in patients with Rabson—Mendenhall syndrome prevents compensation of diabetes mellitus. Chronic glucosotoxicity in these children leads to progression of diabetic complications and to early disability. The literature reports single cases of long-term follow-up of patients with Rabson—Mendenhall syndrome.

1. Тихонович Ю.В., Малиевский О.А., Тюльпаков А.Н. Синдром Донохью. Описание клинического случая и краткий обзор литературы. // Проблемы эндокринологии. — 2016. — Т. 62. — №2. — С. 42—45. [Tikhonovich YV, Malievsky OA, Tyul’pakov A. Description of the first genetically confirming case with Donahue’s syndrome in Russia. Problems of Endocrinology. 2016;62(2):42-45. (in Russ).]doi: 10.14341/probl201662242-45.

2. Ремизов О.В., Щербачева Л.Н., Юшков П.В. Синдром выраженной селективной инсулинорезистентности с псевдо акромегалией. // Ожирение и метаболизм. — 2006. — Т. 3. — №2. — С. 22—28. [Remizov OV, Shcherbacheva LN, Yushkov PV. Sindrom vyrazhennoi selektivnoi insulinorezistentnosti s psevdoakromegaliei. Obesity and metabolism. 2006;3(2):22—28. (inRuss).] doi: 10.14341/2071-8713-4862.

3. Джонс К.Л. Наследственные синдромы по Дэвиду Смиту: атлас-справочник. Пер. с англ. — М.: Практика; 2011. [DzhonsKL. Nasledstvennye sindromy po Devidu Smitu: atlas-spravochnik. Moscow: Praktika; 2011. (In Russ).]

4. Кураева Т.Л., Зильберман Л.И., Титович Е.В., и др. Генетика моногенных форм сахарного диабета. // Сахарный диабет. — 2011. — Т. 14. — №1. — С. 20—27. [Kuraeva TL, Zil’berman LI, Titovich EV, et al. Genetics of monegenic forms of diabetes mellitus. Diabetes mellitus. 2011;14(1):20—27. (in Russ).] doi: 10.14341/2072-0351-6246.

5. Ткачук В.А., Воротников А.В. Молекулярные механизмы развития резистентности к инсулину. // Сахарный диабет. — 2014. — Т. 17. — №2. — С. 29—40. [Tkachuk VA, Vorotnikov AV. Molecular mechanisms of insulin resistance. Diabetes mellitus. 2014;17(2):29—40. (inRuss).] doi: 10.14341/DM2014229-40.

6. Rabson SM, Mendenhall EN. Familial hypertrophy of pineal body, hyperplasia of adrenal cortex and diabetes mellitus. Am J Clin Pathol. 1956;26(3):283—290. doi: 10.1093/ajcp/26.3.283.

7. Doosoo K, Sung Y, Cho S, et al. Two novel insulin receptor gene mutations in a patient with Rabson—Mendenhall syndrome: the first Korean case confirmed by biochemical, and molecular evidence. J Korean Med Sci. 2012;27(5):565—568. doi: 10.3346/jkms.2012.27.5.565.

8. Takahashi Y, Kadowaki H, Ando A, et al. Two aberrant splicings caused by mutations in the insulin receptor gene in cultured lymphocytes from a patient with Rabson—Mendenhall’s syndrome. J ClinInvest. 1998;101(3):588-594. doi: 10.1172/jci1283.

9. Jiang S, Fang Q, Zhang F, et al. Functional characterization of insulin receptor gene mutations contributing to Rabson—Mendenhall syndrome — phenotypic heterogeneity of insulin receptor gene mutations. Endocr J. 2011;58(11):931-940. doi: 10.1507/endocrj.EJ11-0032.

10. Taylor SI, Underhill LH, Hedo JA, et al. Decreased Insulin Binding to Cultured Cells from a Patient with the Rabson-Mendenhall Syndrome: Dichotomy between Studies with Cultured Lymphocytes and Cultured Fibroblasts. J Clin Endocr Metab. 1983;56(4):856-861. doi: 10.1210/jcem-56-4-856.

11. Goutham R. Insulin resistance syndrome. Am Fam Physician. 2001;63(6):1159-1163.

12. Gupta J, Daniel JM, Vasudevan V. Rabson-Mendenhall syndrome. JIndian SocPedodPrevDent.2012;30(3):279—282. doi: 10.4103/0970-4388.105026.

13. Rittey D, Evans J, Gray CE, et al. Melatonin state in Mendenhall’s syndrome. Arch Dis Child Educ Pract Ed. 1988;63(7):852—854.doi: 10.1136/adc.63.7.852.

14. Parveen BA, Sindhuja R. Rabson-Mendenhall syndrome. Int J Dermatol. 2008;47(8):839—841. doi: 10.1111/j.1365-4632.2008.03591.x.

15. Longo N, Wang U, Pasquali M. Progressive decline in insulin levels in Rabson-Mendenhall syndrome. J Clin Endocrinol Metab. 1999;84(8):2623—2629. doi: 10.1210/jcem.84.8.5902.

16. Carla M, Cochran E, Ann S, et al. Clinical course of genetic diseases of the insulin receptor (type A and Rabson-Mendenhall syndromes). Medicine. 2004;83(4):209—222. doi: 10.1097/01.md.0000133625.73570.54.

17. Longo N. Impaired growth in Rabson-Mendenhall syndrome: lack of effect of growth hormone and insulin-like growth factor-I. J ClinEndocrinolMetab.1999;79(3):799-805. doi: 10.1210/jc.79.3.799.

18. Cochran E, Young JR, Sebring N. Efficacy of recombinant methionyl human leptin therapy for the extreme insulin resistance of the Rabson-Mendenhall syndrome. J Clin Endocrinol Metab. 2004;89(4):1548—1554.doi: 10.1210/jc.2003-031952.

19. Brown RJ, Cochran E, Gorden P. Metreleptin improves blood glucose in patients with insulin receptor mutations. J Clin Endocrinol Metab. 2013;98(11):1749—1756. doi: 10.1210/jc.2013-2317.

20. Атанесян Р.А., Климов Л.Я., Вдовина Т.М. и др. Случай синдрома Рабсона—Менденхолла у ребенка 13 лет. // Сахарный диабет. — 2015. — Т. 18. — №1. — С. 110—114. [Atanesyan RA, Klimov LY, Vdovina TM, et al. Rabson-Mendenhall syndrome in a 13 y.o. child (clinical case). Diabetes mellitus. 2015;18(1):110-114. (in Russ).] doi: 10.14341/DM20151110-114.

21. de la Fuente MC, Castellanos RB, Blanco MA, et al. Long survival in Rabson—Mendenhall syndrome. Diabetes Res Clin Pract. 2010;89(2):e17-e18. doi: 10.1016/j.diabres.2010.04.023.